Description

CJC-1295 + Ipamorelin is a research peptide blend commonly studied for its potential role in growth hormone signaling, recovery pathways, metabolic regulation, and body composition research. This dual-compound formulation combines CJC-1295, a growth hormone releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue, to support sustained and targeted GH release in controlled laboratory settings.

Researchers frequently utilize CJC-1295 + Ipamorelin in studies exploring muscle recovery, sleep quality, cellular regeneration, fat metabolism, and age-related hormonal decline. The synergistic interaction between these peptides makes this combination a popular subject in performance and longevity-focused research models.

TruPeptide’s CJC-1295 + Ipamorelin research-grade formula is manufactured in the USA, third-party tested, and purity verified to ensure consistent quality, accuracy, and reproducible research results. Intended strictly for laboratory and research purposes only.